Abstract:Objects To evaluate the therapeutic efficacy of combination therapy of plasma perfusion(PP) and plasma exchange(PE) on patients with liver failure and hyperbilirubinemia.Methods Fifty-one patients(totally 66 person-times) with liver failure and hyperbilirubinemia received a combination therapy of PP and PE with a small amount of plasma.Serum TBIL,TBA,PTA,ALB and WBC were measured before treatment,at the end of treatment and at hour 48 post-treatment.Adverse reactions were closely observed.Thirty-six patients(totally 79 person-times) who simply received PE were taken as the control group.Results The total effective rate of combination therapy group was 60.87%,higher than that of PE group(52.78%),but the difference was not statistically significant between both groups(P >0.05).Serum TBIL levels at the end of treatment and at hour 48 post-treatment were significantly lower than those before treatment in the patients of both groups(P<0.05),and the levels decreased more sharply in the patients of the combination therapy group than in the patients of PE group(P<0.05).The serum levels of TBA in the patients of both groups were lower at the end of treatment than those before treatment(P<0.05),but no significant differences were found between both groups(P>0.05).PTA values of the patients of both groups were higher at the end of treatment than before treatment(P<0.05).Compared with pretherapy,serum ALB and GLO levels in the patients of combination therapy group made no differences at the end of treatment and at hour 48 post-treatment,but those in the patients of PE group decreased significantly(P<0.05).Compared with pretherapy,there were no differences in WBC counts in the patients of both groups at the end of treatment and at hour 48 post-treatment,but PLT counts in the patients of both groups decreased significantly at the end of treatment(P<0.05).The average usage of plasma among the patients of combination therapy group was significantly lower than that among the patients of PE group.No severe adverse reactions were observed.Conclusion The combination therapy of PP and PE uses a smaller amount of plasma,and is safe and effective for the patients with liver failure and hyperbilirubinemia.

A Plasma Exchange Model and Variation of Bilirubin Concentration

Plasma Exchange Model and Its Application

Prediction Value of Model for End-Stage Liver Disease Scoring System on Prognosis in the Acute on Chronic Liver Failure Patients with Plasma Exchange Treatment.

Mathematics models for plasma exchange

Analytical System of Clinical Dosage of Plasma for Artificial Liver

Analysis of Related Factors on Therapeutic Efficacy of Plasma Exchange for the Treatment of Hyperbilirubinemia

Changes in Peripheral CD4+CD25 high Regulatory T Cells in the Acute-on-Chronic Liver Failure Patients with Plasma Exchange Treatment

Comparison of Plasma Exchange with Different Membrane Pore Sizes in the Treatment of Severe Viral Hepatitis

A Prognostic Model for Hepatitis B Acute-on-chronic Liver Failure Patients Treated Using a Plasma Exchange-Centered Liver Support System.

Models for plasma kinetics during simultaneous therapeutic plasma exchange and extracorporeal membrane oxygenation

Plasma exchange treatment using MELD scoring system improve the prognosis of fulminant Hepatitis in Chinese patients

Comparitive study of middle and mixed artificial livers in treatment of hepatic failure

Prevention and Treatment of Liver Failure and Hyperbilirubinemia Complication by Bilirubin Absorption Combined with Plasma Exchange

The effect of neonatal with very severely hyperbilirubinemia treated by plasma exchange

Plasma Exchange-Centered Artificial Liver Support System in Hepatitis B Virus-Related Acute-on-chronic Liver Failure: a Nationwide Prospective Multicenter Study in China.

Clinical observation of plasma exchange in treatment of 41 patients with chronic liver failure

Combination therapy of plasma perfusion and plasma exchange in patients with liver failure and hyperbilirubinemia

[Clinical Research of Plasma Exchange with Continuous Veno-Venous Hemofiltration in Treating Mid- and Late-Stage Chronic Severe Viral Hepatitis B Patients].

Effects of Hemoperfusion Adsorption And/or Plasma Exchange in Treatment of Severe Viral Hepatitis: A Comparative Study

Changes of serum cytokine levels in patients with acute on chronic liver failure treated by plasma exchange.

The MELD Scoring System for Predicting Prognosis in Patients with Severe Hepatitis after Plasma Exchange Treatment.